X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Orchid Chemicals - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs ORCHID PHARMA LTD - Comparison Results

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE ORCHID PHARMA LTD SUVEN LIFE/
ORCHID PHARMA LTD
 
P/E (TTM) x 20.1 -0.6 - View Chart
P/BV x 3.7 0.4 850.3% View Chart
Dividend Yield % 1.0 0.0 -  

Financials

 SUVEN LIFE   ORCHID PHARMA LTD
EQUITY SHARE DATA
    SUVEN LIFE
Mar-16
ORCHID PHARMA LTD
Sep-13
SUVEN LIFE/
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs339194 174.5%   
Low Rs14435 412.6%   
Sales per share (Unadj.) Rs39.2276.5 14.2%  
Earnings per share (Unadj.) Rs7.5-79.2 -9.4%  
Cash flow per share (Unadj.) Rs8.8-43.5 -20.2%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs49.053.9 90.8%  
Shares outstanding (eoy) m127.2870.45 180.7%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x6.20.4 1,485.5%   
Avg P/E ratio x32.4-1.4 -2,238.6%  
P/CF ratio (eoy) x27.5-2.6 -1,044.2%  
Price / Book Value ratio x4.92.1 232.1%  
Dividend payout %26.80-   
Avg Mkt Cap Rs m30,7328,067 381.0%   
No. of employees `0001.02.8 34.1%   
Total wages/salary Rs m4162,527 16.5%   
Avg. sales/employee Rs Th5,236.16,956.1 75.3%   
Avg. wages/employee Rs Th436.5902.5 48.4%   
Avg. net profit/employee Rs Th995.5-1,993.0 -50.0%   
INCOME DATA
Net Sales Rs m4,99519,477 25.6%  
Other income Rs m194407 47.5%   
Total revenues Rs m5,18919,884 26.1%   
Gross profit Rs m1,2331,103 111.8%  
Depreciation Rs m1672,519 6.6%   
Interest Rs m545,227 1.0%   
Profit before tax Rs m1,205-6,236 -19.3%   
Minority Interest Rs m020 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0511 0.0%   
Tax Rs m255-125 -203.7%   
Profit after tax Rs m950-5,580 -17.0%  
Gross profit margin %24.75.7 435.9%  
Effective tax rate %21.22.0 1,054.3%   
Net profit margin %19.0-28.7 -66.4%  
BALANCE SHEET DATA
Current assets Rs m4,98611,014 45.3%   
Current liabilities Rs m1,04232,060 3.3%   
Net working cap to sales %79.0-108.1 -73.1%  
Current ratio x4.80.3 1,392.5%  
Inventory Days Days6195 64.3%  
Debtors Days Days3934 116.6%  
Net fixed assets Rs m3,12629,440 10.6%   
Share capital Rs m127705 18.1%   
"Free" reserves Rs m3,7172,043 182.0%   
Net worth Rs m6,2363,800 164.1%   
Long term debt Rs m4329,018 4.8%   
Total assets Rs m8,07946,510 17.4%  
Interest coverage x23.2-0.2 -12,027.2%   
Debt to equity ratio x0.12.4 2.9%  
Sales to assets ratio x0.60.4 147.6%   
Return on assets %12.4-0.8 -1,634.9%  
Return on equity %15.2-146.9 -10.4%  
Return on capital %18.9-3.7 -505.5%  
Exports to sales %87.537.9 231.0%   
Imports to sales %12.222.6 54.1%   
Exports (fob) Rs m4,3717,378 59.2%   
Imports (cif) Rs m6114,406 13.9%   
Fx inflow Rs m4,6667,513 62.1%   
Fx outflow Rs m9425,649 16.7%   
Net fx Rs m3,7241,865 199.8%   
CASH FLOW
From Operations Rs m9221,682 54.8%  
From Investments Rs m-619-9,860 6.3%  
From Financial Activity Rs m-6986,644 -10.5%  
Net Cashflow Rs m-396-1,535 25.8%  

Share Holding

Indian Promoters % 63.4 32.3 196.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 4.6 -  
FIIs % 0.0 3.3 -  
ADR/GDR % 0.0 4.6 -  
Free float % 36.5 55.3 66.0%  
Shareholders   37,287 84,811 44.0%  
Pledged promoter(s) holding % 0.0 54.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   JUBILANT LIFE SCIENCES  PANACEA BIOTECH  CADILA HEALTHCARE  ABBOTT INDIA  PLETHICO PHARMA  

Compare SUVEN LIFE With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty Close at Record Highs; Bank & Realty Stocks Rally(Closing)

After opening the day marginally higher, Indian share markets extended gains in the afternoon session after the government decided to cut tax rates on certain products and services.

Related Views on News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Jan 19, 2018 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE SUVEN LIFE WITH

MARKET STATS